CA-125 is an effective marker for patients with external endometriosis and on danazol: case reports

Case report OA: closed public-domain-us
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-02 ⓘ

This case series analyzed serum CA-125 levels over time in four patients with external endometriosis treated with danazol, finding CA-125 useful for predicting relapse.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Serum levels of CA-125 in women with external endometriosis and on danazol were assayed for an extended period, and changes in the CA-125 pattern were analyzed. Whereas the prognosis for the patients in case 1 was good, those for cases 2, 3, and 4 were poor. We propose that the Ca-125 levels should be carefully determined for individual patients, because a relapse can be predicted.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Antigens, Neoplasm Danazol Endometriosis Pregnadienes Adult Adult Antigens, Neoplasm Antigens, Neoplasm Antigens, Tumor-Associated, Carbohydrate Antigens, Tumor-Associated, Carbohydrate Danazol Danazol Endometriosis Endometriosis Endometriosis Female Female Humans Humans Pregnadienes

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-19T06:17:24.038039+00:00
pubmed
last seen: 2026-10-08T21:25:50.035457+00:00
unpaywall
last seen: 2026-10-09T06:36:44.367587+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine